Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Science Times Observer.
Press releases published on May 29, 2025
RIB Software Launches Global Customer Campaign: “You See It. Together, We’ll See It Through”
GlobeNewswire
·
May 29, 2025
Stuttgart, Germany, May 29, 2025 (GLOBE NEWSWIRE) -- Stuttgart, Germany – May 2025 – RIB Software, a global leader in engineering and construction software technology, today announced the launch of its latest global brand campaign: “You See It. Together, …
Alumis to Present at the Jefferies Global Healthcare Investor Conference
GlobeNewswire
·
May 29, 2025
SOUTH SAN FRANCISCO, Calif., May 29, 2025 (GLOBE NEWSWIRE) -- Alumis Inc. (Nasdaq: ALMS), a late-stage biopharma company developing next-generation targeted therapies for patients with immune-mediated diseases, today announced that Martin Babler, President …
Microchip Technology Raises Financial Guidance for Sales and EPS for First Quarter of Fiscal Year 2026
GlobeNewswire
·
May 29, 2025
CHANDLER, Ariz., May 29, 2025 (GLOBE NEWSWIRE) -- Microchip Technology Incorporated, a leading provider of smart, connected, and secure embedded control solutions, today updated the range of its prior guidance for net Sales and GAAP and non-GAAP earnings …
Fulcrum Therapeutics to Present at Upcoming Medical Meetings
GlobeNewswire
·
May 29, 2025
CAMBRIDGE, Mass., May 29, 2025 (GLOBE NEWSWIRE) -- Fulcrum Therapeutics, Inc.® (the “Company”) (Nasdaq: FULC), a clinical-stage biopharmaceutical company focused on developing small molecules to improve the lives of patients with genetically defined rare …
Kevin Rubin Joins Zscaler as Chief Financial Officer to Drive Continued Growth
GlobeNewswire
·
May 29, 2025
SAN JOSE, Calif., May 29, 2025 (GLOBE NEWSWIRE) -- Zscaler, Inc. (NASDAQ: ZS), the leader in cloud security, today announced the appointment of Kevin Rubin as Chief Financial Officer. In his role, Rubin will oversee Zscaler’s global finance organization …
Relay Therapeutics to Participate in Two Upcoming Investor Conferences in June
GlobeNewswire
·
May 29, 2025
CAMBRIDGE, Mass., May 29, 2025 (GLOBE NEWSWIRE) -- Relay Therapeutics, Inc. (Nasdaq: RLAY), a clinical-stage precision medicine company transforming the drug discovery process by combining leading-edge computational and experimental technologies, today …
NextCure and LigaChemBio to Present Trial in Progress Poster for LNCB74, a B7-H4 Targeted Antibody-Drug Conjugate, as Monotherapy in Participants with Advanced Solid Tumors at ASCO 2025
GlobeNewswire
·
May 29, 2025
LNCB74 is in a Phase 1, open-label, first-in-human study that will include dose escalation, safety, and biomarker backfills and randomized dose expansion/optimization The study is currently enrolling in dose escalation Poster to be presented June 2, 2025, …
Ambarella, Inc. Announces First Quarter Fiscal Year 2026 Financial Results
GlobeNewswire
·
May 29, 2025
SANTA CLARA, Calif., May 29, 2025 (GLOBE NEWSWIRE) -- Ambarella, Inc. (NASDAQ: AMBA), an edge AI semiconductor company, today announced first quarter fiscal 2026 financial results for the period ended April 30, 2025. Revenue for the first quarter of fiscal …
Zeo Energy Corp. Receives Nasdaq Notice on Late Filing of its Form 10-Q
GlobeNewswire
·
May 29, 2025
NEW PORT RICHEY, Fla., May 29, 2025 (GLOBE NEWSWIRE) -- Zeo Energy Corp. (Nasdaq: ZEO) “Zeo Energy” or the “Company”), announced today that, as expected, it received a notice (the “Notice”) from Nasdaq on May 22, 2025, notifying the Company that it is not …
Annexon Biosciences to Present at the Jefferies Global Healthcare Conference
GlobeNewswire
·
May 29, 2025
BRISBANE, Calif., May 29, 2025 (GLOBE NEWSWIRE) -- Annexon, Inc. (Nasdaq: ANNX), a biopharmaceutical company advancing a late-stage clinical platform of novel therapies for people living with devastating classical complement-mediated neuroinflammatory …
Terns Pharmaceuticals to Participate in Upcoming June Investor Conferences
GlobeNewswire
·
May 29, 2025
FOSTER CITY, Calif., May 29, 2025 (GLOBE NEWSWIRE) -- Terns Pharmaceuticals, Inc. (“Terns” or the “Company”) (Nasdaq: TERN), a clinical-stage biopharmaceutical company developing a portfolio of small-molecule product candidates to address serious diseases, …
Structure Therapeutics to Participate in Multiple Upcoming Healthcare Investor Conferences
GlobeNewswire
·
May 29, 2025
SAN FRANCISCO, May 29, 2025 (GLOBE NEWSWIRE) -- Structure Therapeutics Inc. (NASDAQ: GPCR), a clinical-stage global biopharmaceutical company developing novel oral small molecule therapeutics for metabolic diseases, today announced that management will …
Kiniksa Pharmaceuticals to Present at Upcoming Investor Conferences
GlobeNewswire
·
May 29, 2025
LONDON, May 29, 2025 (GLOBE NEWSWIRE) -- Kiniksa Pharmaceuticals International, plc (Nasdaq: KNSA) today announced that management will present at the following investor conferences in June: Jefferies 2025 Global Healthcare Conference on Thursday, June 5 …
Beam Therapeutics Announces U.S. FDA Orphan Drug Designation Granted to BEAM-302 for the Treatment of Alpha-1 Antitrypsin Deficiency (AATD)
GlobeNewswire
·
May 29, 2025
CAMBRIDGE, Mass., May 29, 2025 (GLOBE NEWSWIRE) -- Beam Therapeutics Inc. (Nasdaq: BEAM), a biotechnology company developing precision genetic medicines through base editing, today announced that the United States (U.S.) Food and Drug Administration (FDA) …
Gyre Therapeutics Announces Closing of its Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional Shares
GlobeNewswire
·
May 29, 2025
SAN DIEGO, May 29, 2025 (GLOBE NEWSWIRE) -- Gyre Therapeutics (“Gyre”) (Nasdaq: GYRE), an innovative, commercial-stage biopharmaceutical company dedicated to advancing fibrosis-first therapies across organ systems affected by chronic disease, today …
Cytokinetics to Participate in the Jefferies Global Healthcare Conference
GlobeNewswire
·
May 29, 2025
SOUTH SAN FRANCISCO, Calif., May 29, 2025 (GLOBE NEWSWIRE) -- Cytokinetics, Incorporated (Nasdaq: CYTK) today announced that members of the Company’s management team are scheduled to participate in a fireside chat at the Jefferies Global Healthcare …
Arcutis to Present at the Goldman Sachs 46th Annual Global Healthcare Conference
GlobeNewswire
·
May 29, 2025
WESTLAKE VILLAGE, Calif., May 29, 2025 (GLOBE NEWSWIRE) -- Arcutis Biotherapeutics, Inc. (Nasdaq: ARQT), a commercial-stage biopharmaceutical company focused on developing meaningful innovations in immuno-dermatology, today announced that Arcutis …
ELECFREAKS Unveils XGO-Rider: An Engaging Two-Wheeled Self-Balancing Robot for micro:bit
EIN Presswire
·
May 29, 2025
ELECFREAKS unveils XGO-Rider for micro:bit—a compact, self-balancing robot with omnidirectional movement and easy coding, making STEM learning fun …
Colaboración de Mavenir con Three UK y Red Hat duplica las velocidades 5G en Glasgow en el primer lanzamiento de celdas pequeñas Open RAN en el Reino Unido
GlobeNewswire
·
May 29, 2025
Las celdas pequeñas Open vRAN y compatibles con O-RAN de Mavenir son fundamentales para el éxito del lanzamiento de Three UK en el centro de la ciudad de Glasgow, aumentando la cobertura y la capacidad en un entorno urbano denso y de alta demanda La prueba …
שיתוף פעולה של Mavenir עם Three UK ו-Red Hat מכפיל את מהירויות ה-5G בגלזגו בפריסת תאי Open RAN קטנים ראשונה בבריטניה
GlobeNewswire
·
May 29, 2025
לתאים הקטנים תואמי Open vRAN ו-O-RAN של Mavenir יש חלק מרכזי בהצלחת הפריסה של Three UK במרכז גלזגו - שמחזקת את הכיסוי והקיבולת בסביבה עירונית צפופה בה הביקוש גבוה ניסוי פורץ דרך מדגים את היתרון של פריסת תאי Open RAN קטנים לצד רשתות מאקרו קיימות כדי לפתור …